You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

FRUQUINTINIB - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for fruquintinib and what is the scope of freedom to operate?

Fruquintinib is the generic ingredient in one branded drug marketed by Takeda Pharms Usa and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Fruquintinib has sixty-eight patent family members in thirty-two countries.

One supplier is listed for this compound.

Summary for FRUQUINTINIB
International Patents:68
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Clinical Trials: 84
Patent Applications: 139
What excipients (inactive ingredients) are in FRUQUINTINIB?FRUQUINTINIB excipients list
DailyMed Link:FRUQUINTINIB at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for FRUQUINTINIB
Generic Entry Date for FRUQUINTINIB*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY
Dosage:
CAPSULE;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for FRUQUINTINIB

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Peking UniversityN/A
Zhejiang Cancer HospitalPhase 1/Phase 2
Fudan UniversityN/A

See all FRUQUINTINIB clinical trials

US Patents and Regulatory Information for FRUQUINTINIB

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Usa FRUZAQLA fruquintinib CAPSULE;ORAL 217564-001 Nov 8, 2023 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FRUZAQLA fruquintinib CAPSULE;ORAL 217564-001 Nov 8, 2023 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FRUZAQLA fruquintinib CAPSULE;ORAL 217564-001 Nov 8, 2023 RX Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Takeda Pharms Usa FRUZAQLA fruquintinib CAPSULE;ORAL 217564-001 Nov 8, 2023 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FRUZAQLA fruquintinib CAPSULE;ORAL 217564-002 Nov 8, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FRUZAQLA fruquintinib CAPSULE;ORAL 217564-002 Nov 8, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa FRUZAQLA fruquintinib CAPSULE;ORAL 217564-002 Nov 8, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for FRUQUINTINIB

Country Patent Number Title Estimated Expiration
Japan 2011519956 ⤷  Sign Up
European Patent Office 3191475 FORMES CRISTALLINES DU 6-((6,7-DIMÉTHOXYQUINAZOLIN-4-YL)OXY)-N,2-DIMÉTHYLBENZOFURAN-3-CARBOXAMIDE (CRYSTALLINE FORMS OF 6-((6, 7-DIMETHOXYQUINAZOLIN-4-YL)OXY) -N,2-DIMETHYLBENZOFURAN-3-CARBOXAMIDE) ⤷  Sign Up
Singapore 11201701544U CRYSTALLINE FORMS OF 6- ( (6, 7-DIMETHOXYQUINAZOLIN-4-YL) OXY) -N,2-DIMETHYLBENZOFURAN-3-CARBOXAMIDE ⤷  Sign Up
China 111018846 化合物晶型 (Compound crystal form) ⤷  Sign Up
Peru 20170661 FORMAS CRISTALINAS DE 6-((6,7-DIMETOXIQUINAZOLIN-4-IL)OXI)-N,2-DIMETILBENZOFURAN-3-CARBOXAMIDA ⤷  Sign Up
South Korea 20170042662 6--N,2-디메틸벤조푸란-3-카르복사미드의 결정형 (6-67--4--N2--3- Crystalline forms of 6-67-dimethoxyquinazolin-4-yloxy-N2-dimethylbenzofuran-3-carboxamide) ⤷  Sign Up
Eurasian Patent Organization 034730 ФОРМА I СОЕДИНЕНИЯ 6-((6,7-ДИМЕТОКСИХИНАЗОЛИН-4-ИЛ)ОКСИ)-N,2-ДИМЕТИЛБЕНЗОФУРАН-3-КАРБОКСАМИДА, СПОСОБ ЕГО ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ И СПОСОБ ЛЕЧЕНИЯ (FORM I OF COMPOUND 6-((6,7-DIMETHOXYQUINAZOLIN-4-YL)OXY)-N,2-DIMETHYLBENZOFURAN-3-CARBOXAMIDE, METHOD OF PREPARING SAME, USE AND METHOD OF TREATMENT) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.